Please use this identifier to cite or link to this item: https://idr.l2.nitk.ac.in/jspui/handle/123456789/12193
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEswaran, S.
dc.contributor.authorAdhikari, A.V.
dc.contributor.authorAjay, Kumar, R.
dc.date.accessioned2020-03-31T08:38:46Z-
dc.date.available2020-03-31T08:38:46Z-
dc.date.issued2010
dc.identifier.citationEuropean Journal of Medicinal Chemistry, 2010, Vol.45, 3, pp.957-966en_US
dc.identifier.urihttp://idr.nitk.ac.in/jspui/handle/123456789/12193-
dc.description.abstractA new class of fused oxazoloquinoline derivatives was synthesized starting from 2-bromo-1-phenylethanones 1a-b through multi-step reactions. The newly synthesized compounds were evaluated for their in vitro antibacterial against Escherichia coli (ATTC-25922), Staphylococcus aureus (ATTC-25923), Pseudomonas aeruginosa (ATCC-27853) and Klebsiella pneumoniae (recultured) and antituberculosis activity against Mycobacterium tuberculosis H37Rv (ATCC 27294). Preliminary results indicated that most of the compounds demonstrated very good antibacterial and antituberculosis activities which are comparable with the first line drugs. Compounds 6a, 6c, 6g, 6j, 6k and 6n emerged as the lead antitubercular agents with MIC, 1 ?g/mL and 99% bacterial inhibition while eight compounds, viz., 5a, 15k, 6a, 6c, 6g, 6j, 6k and 6n were found to be more potent than INH (MIC: 1.5 ?g/mL) with MIC 1 ?g/mL. 2009 Elsevier Masson SAS. All rights reserved.en_US
dc.titleNew 1,3-oxazolo[4,5-c]quinoline derivatives: Synthesis and evaluation of antibacterial and antituberculosis propertiesen_US
dc.typeArticleen_US
Appears in Collections:1. Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.